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Abstract
Background: The majority of cases of endophthalmitis are caused by exogenous pathogens; only 5–10 % are of
endogenous origin. One cause of these rare cases of endogenous endophthalmitis is Listeria monocytogenes.
Twenty-six cases of endophthalmitis due to this pathogen have been published over the last twenty years. The aim
of this review is to summarize the main risk factors and common clinical findings of endogenous endophthalmitis
due to Listeria monocytogenes.
Case presentation: We report on a 62-year-old female presenting with a sterile hypopyon iritis with secondary
glaucoma and an underlying rheumatoid disease. In microbiological analysis we identified Listeria monocytogenes.
Further we searched through all published cases for typical signs, risk factors, details of medical and surgical
treatment and outcome of endogenous endophthalmitis due to this rare pathogen.
Ocular symptoms in almost all of these published cases included pain, redness of the eye, and decreased vision.
Main clinical features included elevated intraocular pressure and fibrinous anterior chamber reaction, as well as a
dark hypopyon. While the infection is typically spread endogenously, neither an exogenous nor endogenous source
of infection could be identified in most cases. Immunocompromised patients are at higher risk of being infected
than immunocompetent patients. The clinical course of endophthalmitis caused by Listeria monocytogenes had
different visual outcomes. In some cases, the infection led to enucleation, blindness, or strong visual loss, whereas
most patients showed a tendency of visual improvement during therapy.
Conclusion: Early diagnosis and treatment initiation are crucial factors in the outcome of endogenous
endophthalmitis caused by Listeria monocytogenes. This possible differential diagnosis should be kept in mind while
treating patients with presumable sterile hypopyon and anterior uveitis having a high intraocular pressure. A
bacterial source should be considered with a prompt initiation of systemic antibiotic treatment, mainly in
immunocompromised patients, who develop endogenous anterior uveitis. An appropriate microbiological sampling
is essential to detect atypical microorganisms and to choose an effective antibiotic treatment.
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Background
Endophthalmitis is a serious intraocular inflammatory
disorder affecting the vitreous cavity that can occur after
ocular surgery, trauma, or as a consequence of systemic
infection [1]. It is one of the most devastating diagnoses
in ophthalmology and often leads to loss of vision.
Therefore, an immediate and effective treatment is
necessary for satisfactory visual results. The most com-
mon form of endophthalmitis is caused exogenously
following ocular surgery (67 %) [2, 3]. About 25 % of
endophthalmitis cases are a result of ocular trauma [4].
Endogenous endophthalmitis accounts for only 5–10 %
of all endophthalmitis cases. This occurs, when microor-
ganisms from the bloodstream reach the eye, cross the
blood-retina barrier, and infect ocular tissue [3, 5–7].
Risk factors include immunocompromised patient,
diabetes mellitus, HIV infection, cancer, renal failure re-
quiring haemodialysis, cardiac disease, steroid therapy,
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and indwelling intravenous catheters [4–7]. The causa-
tive pathogen can be successfully identified in more than
75 % of cases of endogenous endophthalmitis via intra-
ocular specimen, blood culture, cerebrospinal fluid, or
urine [4, 5, 8]. The pathogen Listeria monocytogenes is a
very rare cause of endogenous endophthalmitis. There
have been only twenty-six published cases since
Goodner and Okumoto in 1967 [9–34].
Case presentation
A 62-year-old woman presented to our emergency
department with pain, redness, and decreased vision
in the left eye, as well as nausea and vomiting. She
reported having a “flu like” illness for three days prior
to the referral, without neck stiffness and fever. An-
amnestic the left eye showed initial symptoms of
redness and a slightly blurred vision only two days
before. There was no history of previous trauma,
infection, or surgery. Her medical history was notable
for diabetes mellitus type II, chronic rheumatoid arth-
ritis, spondylitis ankylosans (mainly thoracic), HIT
syndrome, thyroid disease, and obesity. Her regular
medication at home consisted of a systemic therapy
with levothyroxine/potassium iodide 50 μg/100 μg 1-
0-0 for thyroid disease, metformin 1 g 1-0-1 and in-
sulin (Novo Rapid, Levemir) to adjust diabetes melli-
tus and methotrexate 15 mg with folic acid once a
week, as well as adalimumab 40 mg subcutaneous
every 14 days for rheumatoid arthritis. She took
additionally the medication morphine sulphate 30 mg
1-0-1 for chronic pain from rheumatoid arthritis and
spondylitis ankylosans.
In clinical examination upon admission, the patient
denied headache and did not show signs of meningitis
or sinus thrombosis. In the ophthalmological examin-
ation, the VA of the left eye was reduced to 0.5 without
refractive correction (sc) and the initial intraocular pres-
sure was elevated to 48 mmHg. Our examination of the
left eye revealed an injected conjunctiva and microcystic
corneal edema. The anterior chamber contained a fibrin-
ous inflammatory reaction in the pupillary level with a
white hypopyon and hyperemia of the iris. Therefore,
neither the lens nor the ocular fundus could be clearly
visualized. An ultrasound scan of the eye revealed no
evidence of vitreous debris, retinal detachment, or intra-
ocular foreign body (Fig. 1a).
The right eye was asymptomatic and showed no no-
ticeable diagnostic findings, aside from age-appropriate
mild changes of the lens. The VA on the right eye was
0.7 sc and ocular pressure was 11 mmHg. The cover test
revealed an orthophoric status with normal ocular motil-
ity. The vital parameters were in normal range, with the
blood pressure of 140/80 mmHg, pulse 68/minute and a
temperature of 36.6° Celsius.
Our initial diagnosis was an anterior hypertensive uve-
itis of the left eye, considering the history of spondylitis
ankylosans. The elevated intraocular pressure as well as
the hypopyon, were inconsistent with the differential
diagnosis of anterior uveitis in the context of rheumatoid
arthritis. Treatment with local and systemic corticoste-
roids was initiated. Topical brinzolamide (10 mg/ml,
twice per day), timolol (0,5 %, twice per day) and brimo-
nidine (2 mg/ml three times per day), as well as oral ac-
etazolamide 250 mg daily, were administered for
intraocular pressure control.
No significant improvement was seen the following
day (day 2). Differential diagnoses like endogenous en-
dophthalmitis and a neoplastic process were taken into
consideration. Treatment with ciprofloxacin (400 mg
intravenous twice a day), due to patients reported history
of penicillin allergy, and topical kanamycin (5 mg/ml)
and ofloxacin (3 mg/ml) half-hourly was initiated.
Fig. 1 Ultrasonography (B-scan), left eye, day 3. a First look at
8.00 am; vitreous with no evidence of infiltration, no retinal
detachment. b Second look at 2.00 pm; vitreous appears condensed
and infiltrated at the posterior hyaloid membrane compared to the
first look of the day, no retinal detachment
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Towards the evening of the same day (day 2), an in-
creased hypopyon from 1.5 mm to 3 mm was noted,
reinforcing our suspicion of an endogenous endophthal-
mitis. Anterior chamber tap was performed and exam-
ined for microbial pathogens by Gram stain, culturing,
and histopathology. No signs for bacterial or fungal
infections were seen in microscopy. Local therapy was
initiated in the anterior chamber with gentamicin 0.1 ml
(1.0 mg), vancomycin 0.1 ml (1.0 mg) and dexametha-
sone 0.1 ml (1.0 mg). By this time, the intraocular pres-
sure decreased to an acceptable level of 21 mmHg, but
VA was reduced to hand movements vision. Due to the
progressive course of inflammation seen by increasing
hypopyon and beginning vitreous opacities assessed by
ultrasound scan (Fig. 1b), a pars plana vitrectomy was
performed (on day 3). During the surgical procedure a
moderate infiltration of the vitreous could be visualized
without any signs of retina involvement.
The following day, 48 h hours after anterior chamber
irrigation (day 4), the microbiological culture of the
anterior chamber tap showed an infection with Listeria
monocytogenes. The recommended first line therapy for
Listeria monocytogenes ampicillin often combined with
gentamycin could not be administered due to known
allergy to penicillin. Instead, a treatment with merope-
nem 1 g t.i.d. and gentamycin 80 mg t.i.d. intravenously
was initiated.
No gastroenteritic infection was mentioned by the
patient in her (or in her household’s) medical history.
Results from laboratory examinations were unremark-
able and blood cultures were negative in microbiological
examination. Chest X ray and transthoracic echocardiog-
raphy showed no sign for a pathological process. Com-
puter tomography of skull and orbita showed signs of
ethmoidal sinusitis without evidence of bony erosions.
Retrobulbar soft tissue and the cerebrum were unre-
markable, and no signs of brain abscess could be identi-
fied. The ability to assess the abdominal ultrasound scan
was significantly restricted due to flatulence and obesity.
The ultrasound revealed hepatosplenomegaly and a
status after cholecystectomy. No free liquid or any other
evidence of colitis in the abdomen could be seen. A
magnetic resonance imaging was refused by the patient
due to claustrophobia, as was a lumbar puncture for fur-
ther diagnosis. An extensive systemic evaluation failed to
identify the source of Listeria monocytogenes infection.
Additionally, there were no unusual incidences of infec-
tions noted in our clinic or in the city during this time
period.
During this anti-infective treatment, and after the pre-
vious performed anterior chamber tap irrigation and
pars plana vitrectomy, hypopyon did not reoccur. The
inflammatory cells in the anterior chamber still per-
sisted. Further the intraocular pressure increased to
values over 35 mmHg, which required another lavage
and irrigation with gentamicin, vancomycin and dexa-
methasone of the anterior chamber (on day 10). The
clinical situation stabilized after this intervention and
the inflammation of the anterior chamber slowly
resolved. However, VA was limited and unsteady
between 0.05 sc and 0.16 sc due to a severe corneal
edema and a cataract that had developed in the patient’s
eye. Patient signed out against medical advice after nine-
teen days of hospitalization. The VA at that time was on
the left eye 0.1 sc and the intraocular pressure 10 mmHg.
The eye showed conjunctival injection, the cornea had a
5.6 × 3.9 mm epithelial defect, descemet folds, and endo-
thelial pigmentation. The anterior chamber was deep
without inflammatory cells and the pupil showed poster-
ior synechiae. The ultrasound scan showed a circumfer-
entially attached retina and no signs for vitreous debris.
Patient left with current topical steroid and antibiotic ther-
apy consisting of prednisolonacetat (10 mg/ml) 8×/day,
kanamycin (5 mg/ml), and ofloxacin (3 mg/ml) each 5×/
day, as well as systemic corticosteroids 20 mg once daily.
Twenty-two weeks later the patient consulted our
ward again with symptoms of pressure on the left eye
and enhanced epiphora. The VA was reduced to hand
movements vision and the IOP was 33 mmHg. The slit
lamp examination of the left eye revealed a corneal
edema, central endothelial precipitates and a circular
injected conjunctiva. The anterior chamber was com-
pletely free of irritation without a hypopyon or other
signs for an anterior uveitis. Due to a dense cataract the
fundus could not be visualized (Fig. 2a). An ultrasound
scan of the eye revealed no evidence of vitreous debris
or signs of endophthalmitis. In the absence of inflamma-
tory signs, we assumed an increasing cataract with pro-
gressive narrowing of the chamber angle to be
responsible for the elevated intraocular pressure. A pha-
coemulsification of the lens was performed, followed by
an implantation of an intraocular lens. The VA improved
after the operation to 0.5 sc, while the intraocular pres-
sure remained normotensive. The fundus showed unre-
markable findings with normal configuration of retinal
macula layers shown in an optical coherence examin-
ation (Fig. 2b, c, d). An autoimmune component source
could not be excluded.
Five weeks later the patient complained about severe
pain of the left eye, nausea, and vomiting. We saw a de-
compensation of the intraocular pressure on the left eye
up to 58 mmHg. VA dropped to counting fingers. Due
to a massive corneal edema, any further examination of
the eye was not possible. After reduction of eye pressure
and clearing of cornea, a hyperemic iris and cellular
infiltration of the anterior chamber could be noted.
There was no infiltration of the retina or vitreous. To
exclude a relapse of endophthalmitis, samples of the
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anterior chamber and blood cultures for microbiological
examination were taken. So far there was the possibility
of a relapse of the endophthalmitis with Listeria monocy-
togenes. For this reason an antibiotic therapy with mero-
penem, gentamicin and a systemic steroid therapy
(80 mg once daily) was initiated. An investigation of
potential origin of infection was taken up again, without
any positive results (chest x-ray, urine status, abdominal
ultrasound scan, and differential blood count). The
sample of the anterior chamber was sterile in microbio-
logical examination, and a PCR for herpes simplex virus
was negative. The blood cultures showed Staphylococcus
capitis, most likely in the context of contamination,
since the patient had no systemic signs of infection or
endocarditis. Intravenous therapy was continued for
thirteen days, followed by oral therapy with minocyclin
150 mg twice a day for four weeks.
Last clinical examination of the patient, twenty-seven
months after first consultation, showed no inflammation
of anterior chamber or vitreous of the left eye. The VA
on the left eye was 0.7 with the best correction and the
intraocular pressure was 10 mmHg.
Today (after 35 months) the patient reported contin-
ued use of local therapy with corticosteroids three times
a day. Any attempted withdrawal trials led to renewed
opacities and blurred vision. With this single treatment
without any antibiotics, there have been no further
ophthalmologic problems or other signs for a systemic
infectious disease. Therefore, we assume a complete
healing of the bacterial infection, but a lasting chronic
uveitis.
Review on symptoms, clinic, treatment and
outcome of published cases
We reviewed all published cases describing endophthal-
mitis caused by Listeria monocytogenes between 1967
and May 2014 via research on PubMed. The search was
performed using the keywords “Listeria”, “endophthalmi-
tis” and “endogenous”. Only articles written in English
and German are reviewed, although some key parame-
ters from previously reviewed articles originally written
in French were included.
Ocular symptoms in almost all cases included pain
(20/23; 87 %), redness of the eye (15/23; 65 %) and de-
creased vision (13/23; 56 %). The only other described
symptom was photophobia (3/23; 13 %), which occurred
relatively seldom as it is a common symptom of uveitis.
The clinical features included elevated intraocular
pressure and fibrinous anterior chamber reaction
(Table 1). Several patients developed a dark hypopyon
(23/27; 85 %). The median age of the patients was 62
(interquartile range (IQR) =18) years, with the youngest
being 24 and the oldest at 88 years (Table 1, 2). The
present case, as well as nine of the twenty-six published
cases of L. monocytogenes endophthalmitis, occurred in
immunocompromised patients (37 %) [11, 14, 17, 19, 22,
Fig. 2 Complicated cataract with elevated intraocular pressure. Slit lamp examination of the left eye showing a dense cataract with no
visualization of the fundus (a). Three days after performing cataract surgery (b, c). Optical coherence tomography of the macula (d)
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25, 27, 29, 34]. Five cases (19 %) occurred in patients
with chronic diseases such as neurodermitis, sacroiliitis,
diabetes mellitus (present case), arterial hypertension,
hypothyroidism, or previous history of cancer or surgery
(coronary artery bypass graft) [16, 21, 24, 26, 30] (Table
2) . Six cases (22 %) occurred in elderly patients (age
62–76) in good physical health [9, 10, 12, 13, 18, 23, 33],
and the remaining four cases (15 %) affected young (age
27–47), healthy individuals [20, 28, 31, 32]. More specific-
ally, the recently published cases describe two young
patients (age 27, 28), both having a history of refractive
ocular surgery [31, 32]. In both of these cases, an exogen-
ous infection is more apparent, whereas in all other re-
ported cases an exogenous source of infection could not
be identified.
Listeria monocytogenes is a catalase-positive and gram-
positive rod that exhibits weak beta-haemolytic growth on
blood agar. It is ubiquitously found and colonizes a wide
variety of animals, soil, and vegetables. Transmission usually
occurs via ingestion of contaminated food or by colonized










1 [9] 76 M 43 Red, uncomfortable, irritation, pain,
poor vision
+ + Acute anterior uveitis
2 [10] 62 M 44 Asymptomatic redness, decreased
vision the following day
+ + Anterior uveitis and corneal edema
3 [11] 69 M 39 Redness, pain + Acute iritis with secondary glaucoma
4 [12] 68 M 68 Redness, photophobia, pain + + + Anterior uveitis and corneal edema
5 [13] 68 F 52 Sudden onset of pain, decreased
visual acuity
+ + Necrotic ciliary body melanoma DD
glaucomacyclitic crisis
6 [14] 57 F 30 Sudden onset of pain one week
before
+ + +
7 [15] 49 F 46 + +
8 [16] 63 M 45 Pain, photophobia, decreased vision + + + Acute anterior hypertensive uveitis
9 [17] 50 F 40 + +
10 [18] 75 M 32 Pain, redness 2 days prior + + +
11 [19] 52 M 50 Itching, redness and pain +
12 [34] 76 F 44 + +
13 [20] 47 F 42 Pain, 6 days prior + + Anterior hypertensive uveitis
14 [21] 67 F 42 Pain, redness, decreased vision
15 [22] 55 M 50 Decreased vision and pain of the eye + + +
16 [23] 73 M 37 Redness, pain, blurred vision since
2 days
+ + + Granulomatoes anterior uveitis
17 [24] 51 F 44 Irritation, pain, decreased vision + +
18 [25] 62 M High Pain, redness, decreased vision Acute hypertensive uveitis
19 [26] 24 F 4 + Local panuveitis
20 [27] 62 M >50 Decreased vision, redness and pain of
the eye
+
21 [28] 41 F 44 Redness of the eye, pain, headache + + + Uveitis anterior secondary glaucoma
22 [29] 67 M 35 Pain, blurred vision increasing





62 F 48 Pain, Redness, Blurred vision + + Iritis with steril hypopyon
24 [30] 88 F 47 Acute blurred vision, increasing pain,
redness
+ - +
25 [31] 27 M 18 Redness, photophobia, decreased
vision
+ Keratoconjunctivitis
26 [32] 28 M 50 Redness, pain 5 days prior + Uveitis
27 [33] 70 M 26 Declined vision + Panuveitis
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gastrointestinal tract, in the case of mother to fetus trans-
mission. Isolation of Listeria monocytogenes from non-sterile
origins can be difficult. In history, for enhanced recovery,
the cold enrichment procedure was done. Nowadays cultur-
ing of this pathogen is easily performed by standard media
and lab procedures, in our case identification was performed
by MALDI-TOF MS (matrix-assisted laser desorption &
ionization time-of-flight mass spectrometry) analysis.
The cause of bacterial endophthalmitis was isolated by re-
covering Listeria monocytogenes from the anterior chamber
(18/21; 86 %), vitreous fluid (7/9; 78 %), or in three cases
from blood cultures (3/13; 23 %) (Table 2) [18, 22, 30].
The direct performed Gram stain from ocular samples
was positive in only six (40 %) of fifteen published cases,
which emphasizes the role of the microbiology culture
with a higher sensitivity from ocular tissue (aqueous 18/
21; 85 % and vitreous 7/9; 77 %) and blood cultures (3/
13; 23 %). Nevertheless, the time period between the
clinical presentation of the patient and a positive micro-
biological identification depends on selected samples,
the bacterial load in the sample, prior administered anti-
infective drugs, and techniques for identification of
pathogens (e.g., biochemical profiling, PCR methods).
The time between the presentation of the patient and
the beginning of an effective treatment against Listeria
monocytogenes in the reviewed cases had a wide range
between 4 and 32 days (mean 13.0 days, IQR = 12).
Endophthalmitis is a serious clinical problem with dif-
ficult management and often a very poor visual outcome
[2, 5]. The final VA in patients with bacterial-caused en-
dogenous endophthalmitis treated with the according
antibiotics is in 70 % of all cases reduced to counting
fingers or less [5]. The literature review by Jackson et al.
found liver abscess (with Klebsiella pneumoniea as dom-
inant species) to be the most common extraocular foci
of infection, followed by pneumonia, endocarditis, soft
tissue infection, urinary tract infection, meningitis, septic
arthritis, and orbital cellulitis [5, 35]. Likely due to
subtherapeutic levels of antibiotics within the eye,
patients with known systemic infection may develop
endophthalmitis [36].
The clinical course of endophthalmitis caused by Lis-
teria monocytogenes had very different outcomes. In sin-
gle cases, the infection led to enucleation, blindness, or
strong visual loss [19, 30, 31, 33]. In eight cases (30 %), a
cataract developed, which led to decreased VA with sub-
sequent cataract surgery [16, 18, 22, 24, 25, 27–29]. Fur-
ther ocular surgical operations were needed in five other
cases (19 %); two patients needed a keratoplasty, and
two other patients needed a trebeculectomy (7 % each)
to manage the secondary glaucoma [13, 21, 22]. One pa-
tient required an additional vitrectomy with membrane
peeling due to a macula hole and an irisprintlens be-
cause of permanent pupillary dilation [28].
Patients with a high VA on admission show further
improvement; in only one case, an initial VA of over 0.1
resulted in a decreased visual outcome. Even patients
with initial very low VA of < 0.1 showed a tendency to
recover and actually reach 1.0 VA. Overall, in seven
cases, the VA had significantly improved to at least 0.6
or had completely recovered (Fig. 3), which can be ex-
plained by the main focus of inflammation in the






Age distribution 24–88 27/27
Gender 15 M/12 F 27/27
Immuno compromised 10 24/27
Diabetes mellitus 2 24/27
History of cancer 5 24/27
Flu like symtoms 7 15/27
Initial therapy: In total
Only corticosteroide 12 22/27
Corticosteroids with additional antibiotics 8
Diagnostic: In total
Direct Gram stain 6 pos/9 neg 15/27
Aquous culture 18 pos/3
neg
21/27
Intraocular culture 7 pos/ 2
neg
9/27
Blood culture 3 pos/10
neg
13/27
Final therapy: In total

















Intraocular (intracameral/ -vitreal) 2/8
Time between onset and treament 4 to
32 days
24/27
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anterior segment of the eye with little or late involve-
ment of the retina [15, 17, 20, 23, 24, 26, 28]. After re-
solving of the hypopyon and clearing of the anterior
chamber, VA increases. When the starting VA is below
0.05, the chance of improvement adds up to only 35.3 %.
The remaining patients maintain low vision or VA
decreases.
The main reasons for a poor visual outcome after
endophthalimitis with Listeria monocytogenes are the
late onset of diagnosis and, therefore, deferred treat-
ment. Many patients are initially misdiagnosed due to
the rare occurrence of this infection and also because
the patients present with similar symptoms and ocular
findings to sterile uveitis in the beginning of the disease
(Table 1). Surprisingly, the initial treatment did not
always have a high impact on visual outcome. In the
group of patients treated with only corticosteroids at the
onset of the disease, only five patients with an initial VA
of 0.2 and HM even reached a visual outcome of 0.8 or
1.0. The remaining seven patients, on the other hand,
did not reach a higher VA than 0.25. Unfortunately, the
duration of sole corticosteroidal treatment could not be
resembled in most cases. Whereas in the group of pa-
tients which were treated with corticosteroids and anti-
biotics, only two cases (including the present case)
showed a visual outcome of higher than 0.4. Here, a
Fig. 3 Visual acuity on admission and visual outcome. Visual acuity (VA) after stabilization of the ocular condition (visual outcome) was compared
to VA at the time of admission to the hospital. For better graphical illustration, counting fingers (CF) and hand movements vision (HM) were
converted into a decimal VA of 0.010 for CF and 0.0052 for HM according to the FrACT measures [42]. Since light perception could not be
assigned to a specific decimal number, it was defined as 0 as well as no light perception. Case reports without description of either VA on
admission or visual outcome were not considered [25, 34]
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more advanced stage of the disease on admission is as-
sumed, which would explain the early beginning of anti-
biotic treatment and poor visual outcome, even though
the initial diagnosis was still uveitis.
In the Endophthalmitis Population Study of Western
Australia, Ng et al. observed noticeable changes in the
diagnosis and management of postoperative endophthal-
mitis since 1995. They showed that the visual outcomes
remain poor and have not improved, despite the fact
that overall use of vitrectomy and intravitreal antibiotic
have increased significantly, whereas the use of both
subconjunctival and intravenous antibiotics have de-
creased [37]. Treatment depends on the underlying
cause of endophthalmitis. When the focus is located
extraocularly followed by an alteration in the blood ocu-
lar barriers (compared to exogenous endophthalmitis),
systemic antibiotics can achieve therapeutic levels in the
eye due to the disrupted blood ocular barrier and bac-
tericidal intraocular antibiotic concentrations are real-
ized [38]. The suggestion was made that systemic
antibiotics are more valuable in endogenous endophthal-
mitis than in postoperative or traumatic endoph-
thalmitis. Further, intraocular antibiotic injection and
vitrectomy make only a limited contribution to success-
ful treatment in endogenous infection [8]. On the other
hand, different studies showed that eyes undergoing pars
plana vitrectomy are three times more likely to retain
useful vision. In addition they are three times less likely
to require evisceration or enucleation due to satisfactory
drug concentration in the vitreous by the intravitreal
route [5, 39]. To prevent irreversible tissue destruction
by the absence of adequate antimicrobial concentrations,
intravitreal administration of antibiotics has become the
main basis of endophthalmitis management [39–41]. In
endogenous endophthalmitis the source of infection,
despite of intense diagnostic investigations is often not
found. Further patients with known systemic infection
can develop endophthalmitis despite taking appropriate
therapeutic systemic antibiotics [36]. Listeria monocyto-
genes has a high sensitivity to penicillin; in almost all
cases, the intravenously applied antibiotic was either
penicillin or ampicillin (Table 2). An early treatment
with systemic antibiotic of dosage and frequency
adequate to treat meningitis or other serious infections
is suggested.
Since endogenous endophthalmitis is spread hemato-
genously, the choroids and ciliary body are usually the
primary focuses of infection due to the higher blood
flow. The retina and vitreous often show only secondary
involvement [5]. In the case of infection with Listeria
monocytogenes, the aqueous humor, followed by the
vitreous, showed first signs of infiltration (Table 1). Al-
though initially, in several cases as well as in the present
case, the fundus could not be visualized, after vitrectomy
or clearing of the anterior chamber no retinal involve-
ment could be seen. Only one case described a retinal
involvement which progressed to panophthalmitis and
required enucleation. The further pathological investiga-
tion demonstrated an acute necrotizing panophthalmitis
[33].
Conclusion
Listeria monocytogenes is an uncommon cause of
endopthalmitis. It is mostly spread endogenously by
hematogenous dissemination, although a source of infec-
tion usually cannot be found. Typical clinical findings
for endophthalimitis caused by Listeria monocytogenes
include a massive fibrinous anterior chamber reaction
with an increase of the intraocular pressure. The out-
comes vary from benign reactions, such as mild uveitis,
to severe reactions, like necrotising panophthalmitis. It
is important to undertake appropriate micro sampling in
order to diagnose atypical microorganisms (like Listeria
monocytogenes), and initiate targeted antibiotic treat-
ment, especially in patients who are immunocomprom-
ised. A prompt intervention is recommended in patients
showing progressive eye symptoms.
Abbreviations
CF, counting fingers; HM, hand movements vision; IQR, interquartile range;
MALDI-TOF MS, matrix-assisted laser desorption & ionization time-of-flight
mass spectrometry; sc, without refractive correction; VA, visual acuity
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